gene 2,576 words KG: CATHEAPSIND
Contents

CTSD — Cathepsin D

🧬 Gene Info
Gene SymbolCTSD
Full NameCathepsin D
AliasesCPSD, CLN10
Chromosome11p15.5
Protein TypeProtease
Functionis a lysosomal aspartic protease encoded by the CTSD gene.
Primary ExpressionBrain, liver, macrophages, neurons, microglia
Molecular Weight48 kDa
PathwaysAkt, Angiogenesis, Apoptosis, Autophagy, Blood-Brain Barrier
UniProt IDP07339
NCBI Gene ID1509
Ensembl IDENSG00000103811
GeneCardsCTSD
Human Protein AtlasCTSD
N-terminal lobeContains the activation peptide (propeptide, ~44 amino acids) that blocks the active site; cleavage of this peptide is required for activation
Associated DiseasesAD, ADH, Aging, ALI, Als
Known Drugs/CompoundsCHLOROQUINE, COENZYME Q10, H2S, rapamycin, RAPAMYCIN
InteractionsABCA1, ABCD3, ACTB, Actin, ADRA2A, AGING
KG Connections1555 knowledge graph edges
DatabasesGeneCardsHPASTRING

No AI portrait yet

Knowledge Graph

Related Hypotheses (12)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.85
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.69
Cross-Seeding Prevention Strategy
Score: 0.69
Lysosomal Positioning Dynamics Modulation
Score: 0.69

Related Analyses (6)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived

Related Experiments (7)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Experiment: Multi-Ethnic PD GWAS
clinical · proposed · Score: 0.40
Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
validation · proposed · Score: 0.40
Non-Motor Symptom Progression in Parkinson's Disease — Mecha
clinical · proposed · Score: 0.40
Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel
validation · proposed · Score: 0.40

See Also (1)

Neurodegeneration
disease · KG edge: implicated_in

Knowledge Graph (2 edges)

CATHEAPSIND data_in benchmark_ot_ad_answer_key:CATHEAPSIND
benchmark_ot_ad_answer_key:CATHEAPSIND data_in CATHEAPSIND

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)